OTEZLA 20 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC-Aluminium de 56 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930305744 -
CIP7
3030574 -
CIS
66078074 -
Registration number
EU/1/14/981
What the source publishes
- Holder
- AMGEN EUROPE
- Active ingredients
- APRÉMILAST
- Form
- comprimé pelliculé
- Package
- plaquette(s) thermoformée(s) PVC-Aluminium de 56 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- prescription réservée aux spécialistes et services PEDIATRIE ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services RHUMATOLOGIE ; prescription réservée aux spécialistes et services DERMATOLOGIE ; liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2024-10-21
- Prescription
- Prescription or restricted
Names this record is found by
- OTEZLA 20 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC-Aluminium de 56 comprimé(s)
- OTEZLA 20 mg, comprimé pelliculé
- APRÉMILAST
Complete source data
{
"cis": "66078074",
"cip7": "3030574",
"form": "comprimé pelliculé",
"name": "OTEZLA 20 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC-Aluminium de 56 comprimé(s)",
"cip13": "3400930305744",
"holder": "AMGEN EUROPE",
"routes": [
"orale"
],
"holders": [
"AMGEN EUROPE"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "379.85",
"authorisedOn": "2024-10-21",
"compositions": [
{
"name": "APRÉMILAST",
"nature": "SA",
"strength": "20 mg",
"linkageNumber": "1",
"substanceCode": "41238",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription réservée aux spécialistes et services PEDIATRIE ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services RHUMATOLOGIE ; prescription réservée aux spécialistes et services DERMATOLOGIE ; liste I",
"dispensingFee": "1.02",
"medicinePrice": "378.83",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "OTEZLA 20 mg, comprimé pelliculé",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) thermoformée(s) PVC-Aluminium de 56 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"30%"
],
"marketingDeclaredOn": "2025-06-11",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"APRÉMILAST"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"prescription réservée aux spécialistes et services PEDIATRIE",
"prescription réservée aux spécialistes et services MEDECINE INTERNE",
"prescription réservée aux spécialistes et services RHUMATOLOGIE",
"prescription réservée aux spécialistes et services DERMATOLOGIE",
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/14/981",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930305744"